Pancreatic cancer as a second tumour following treatment of Hodgkin's disease.
Over the past 30 years, the life expectancy in patients with Hodgkin's disease has greatly improved. However, adverse long-term side-effects are now well recognized and development of second malignancies is one of the most important. We report the case of a patient who developed pancreatic cancer 9 years after treatment, with chemotherapy and radiation, for Hodgkin's disease. The increasing number and variety of solid tumours after curative treatment of Hodgkin's disease points to a need for new, less toxic regimens.
Lambert
C
C
Department of Oncology, McGill University, Montréal, Québec, Canada.
Benk
V
V
Freeman
C R
CR
D000328:Adult; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D008297:Male; D009381:Neoplasms, Radiation-Induced / Q000000981:diagnostic imaging / Q000209:etiology; D016609:Neoplasms, Second Primary / Q000000981:diagnostic imaging / Q000209:etiology*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000209:etiology*; D014057:Tomography, X-Ray Computed